Literature DB >> 8813343

B7-mediated costimulation and the immune response.

J Schultze1, L M Nadler, J G Gribben.   

Abstract

In addition to presentation of antigen, T cells require additional or 'costimulatory' signals from antigen-presenting cells. Failure to receive costimulation following antigen presentation renders T cells anergic, and these cells are functionally incapable of proliferating or secreting cytokines in response to subsequent rechallenge. Recent evidence has demonstrated that a critical costimulatory signal is delivered by members of the B7 family. B7-1 (CD80) and B7-2 (CD86) provide costimulation through CD28, their ligand on the T cell. Dysregulation of expression of B7 may be implicated in the pathogenesis of autoimmune disease. In contrast, lack of expression of B7 on tumor cells may explain in part the lack of immune response against the majority of tumors. It may now be possible to exploit this pathway to induce immunological response against tumors. Blockade of this pathway will likely have significant impact on transplantation biology, to induce T-cell anergy and prevent graft rejection and graft-versus-host disease.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8813343     DOI: 10.1016/s0268-960x(96)90040-5

Source DB:  PubMed          Journal:  Blood Rev        ISSN: 0268-960X            Impact factor:   8.250


  19 in total

Review 1.  Reflections on CD8 T-cell activation and memory.

Authors:  David Masopust; Rafi Ahmed
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

2.  Recombinant adenoviral vector expressing human wild-type p53, GM-CSF, and B7-1 genes suppresses the growth of glioma in vivo.

Authors:  Sizhe Feng; Song Han; Dongsheng Pan; Mingpei Liu; Xinli Feng; Tao Dong; Wei Li; Xuezhong Wei
Journal:  Tumour Biol       Date:  2014-01-10

3.  Hepatocellular carcinoma-specific immunotherapy with synthesized α1,3- galactosyl epitope-pulsed dendritic cells and cytokine-induced killer cells.

Authors:  Ying Qiu; Ming-Bao Xu; Mark M Yun; Yi-Zhong Wang; Rui-Ming Zhang; Xing-Kai Meng; Xiao-Hui Ou-Yang; Sheng Yun
Journal:  World J Gastroenterol       Date:  2011-12-28       Impact factor: 5.742

4.  Triple expression of B7-1, B7-2 and 4-1BBL enhanced antitumor immune response against mouse H22 hepatocellular carcinoma.

Authors:  Guoqiang Li; Xiaofeng Wu; Feng Zhang; Xiangcheng Li; Beicheng Sun; Yue Yu; Aihong Yin; Lei Deng; Jie Yin; Xuehao Wang
Journal:  J Cancer Res Clin Oncol       Date:  2010-06-19       Impact factor: 4.553

5.  B7-1 and 4-1BB ligand expression on a myeloma cell line makes it possible to expand autologous tumor-specific cytotoxic T cells in vitro.

Authors:  Zhao-Yang Lu; Maud Condomines; Karin Tarte; Laure Nadal; Marie Claude Delteil; Jean François Rossi; Christophe Ferrand; Bernard Klein
Journal:  Exp Hematol       Date:  2007-03       Impact factor: 3.084

Review 6.  Monoclonal antibodies in the treatment of non-Hodgkin's lymphoma.

Authors:  Michelle A Fanale; Anas Younes
Journal:  Drugs       Date:  2007       Impact factor: 9.546

7.  Chimeric adenoviral vectors incorporating a fiber of human adenovirus 3 efficiently mediate gene transfer into prostate cancer cells.

Authors:  Miho Murakami; Hideyo Ugai; Natalya Belousova; Alexander Pereboev; Paul Dent; Paul B Fisher; Maaike Everts; David T Curiel
Journal:  Prostate       Date:  2010-03-01       Impact factor: 4.104

8.  Defective expression and modulation of B7-2/CD86 on B cells in B cell chronic lymphocytic leukemia.

Authors:  Zhen-sheng Dai; Qin-fen Chen; Hong-zhou Lu; Yi Xie
Journal:  Int J Hematol       Date:  2009-05-09       Impact factor: 2.490

9.  Discordant Expression of Ii and HLA-DR in Thyrocytes: A Possible Pathogenetic Factor in Hashimoto's Thyroiditis.

Authors:  Mujun Yu; Mingzhen Xu; Lou Savas; Ashraf Khan
Journal:  Endocr Pathol       Date:  1998       Impact factor: 3.943

10.  Plasmodium falciparum exposure in utero, maternal age and parity influence the innate activation of foetal antigen presenting cells.

Authors:  Nadine Fievet; Stefania Varani; Samad Ibitokou; Valérie Briand; Stéphanie Louis; René Xavier Perrin; Achille Massougbogji; Anne Hosmalin; Marita Troye-Blomberg; Philippe Deloron
Journal:  Malar J       Date:  2009-11-05       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.